- Sherwin-Williams (NYSE:SHW -1.6%) and Valspar (VAL -1.7%) say their merger is on track to close on schedule by the end of Q1, saying they hope to end “unfounded market rumors” concerning regulatory approvals for the deal.
- SHW and VAL say they continue to believe that no or few asset sales will be required to complete the transaction, given what they is the complementary nature of the businesses.
- The merger deal includes an unusual clause to cut the $113/share purchase price if antitrust regulators demand aggressive divestitures; SHW could walk away entirely if divestitures climb to $1.5B of revenue.